CD8+ T regulatory cells use a novel genetic program that includes CD103 to suppress Th1 immunity in eye-derived tolerance
収録刊行物
-
- Invest. Ophthalmol. Vis. Sci.
-
Invest. Ophthalmol. Vis. Sci. 47 1533-, 2006